发布时间:2019-08-07 17:00 原文链接: PurificationofrecombinantsBRFM166L

Induction of BRF in bacteria and purification on Ni-NTA agarose

Transform BRF plasmid into strain BL21 DE3 (pLysS) or JM25 (DE3 containing the Arg tRNA over expression plasmid under lac iQ control Kanomycin resistant)

Inoculate 6 ml of a saturated overnight culture of the transformed bacteria into 2X 1 Liter of YT Amp (50 ug/ml) (and Kan (30 ug/ml) if using strain JM25) (adding 1-2 drops of antifoam A before autoclaving the YT will decrease the foam in the culture during growth). Incubate at 30 deg till the culture reaches OD600 ~ 0.6. Remove a small 1 ml sample for an uninduced control, and incubate this small sample on the tube roller for an additional 4 hrs.

Induce the large culture with 0.4 mM IPTG (4 ml of 0.1 M IPTG per 1000 ml) and grow at 30 deg. for four hours. Take a small sample of the induced and uninduced cultures and save for analysis of whole cell protein by SDS PAGE.

Harvest cells by centrifugation (4-6g). Resuspend the cell pellet in 160 ml Lysis buffer. The cells can be frozen at this point in liquid N2 and stored at -70 deg.

It is usually a good idea to analyze the BRF induction by analysis of total cell protein before proceeding.

Thaw the lysed cells at room temp. Sonicate 2 times for 30 sec. each time using the large sonicator tip. Alternatively, the cells can be run once through the microfluidizer.

Centrifuge the crude lysate in the GSA rotor for 30 min at 10K RPM.

During the above GSA spin, prepare the Ni-NTA resin for BRF binding. Transfer 12 mls of Ni-NTA affinity bead slurry (50% beads; 6 ml of beads total) to a 50ml conical tube and centrifuge 3min at 3K RPM in the GPR centrifuge.

Equilibrate the beads 2X with Lysis buffer by resuspension and centrifugation.

Add the equilibrated beads to the clarified extract and place on a room temp. shaker platform for 45 min.

Centrifuge the bead-extract mix in the GSA rotor for 5 min at 5K RPM and carefully remove the supernatant (the pellet of beads will not be very firm so it seems best to remove as much supernatant as possible with a pipette and don’t worry if not all the sup. can be removed). Save this supernatant in case there is a problem with the BRF binding.

Resuspend the beads with a small amount of Lysis buffer and transfer to a 50 ml conical tube. Use extra lysis buffer to wash the GSA bottle to remove all beads. Spin in the GRP rotor and carefully remove sup. by dumping (the pellets will not be very firm so it is OK if not all the sup. can be removed. Wash the beads 5X with ~35 ml Wash Buffer.

After the final wash, transfer the beads to 15ml conical tubes with Wash Buffer. Centrifuge the beads and try to remove all of the supernatant with a Pasteur pipette leaving the beads semi-dry.

Add a volume of Elution Buffer which is equal to the volume of the beads (6 ml) and place on a roller at RT for 20 min. Centrifuge the beads in the GPR and remove the supernatant and save; this is the first protein elution. Repeat the elution and freeze samples. Analyze recovery by SDS PAGE and/or protein assay. Typical recovery is 2 to 6 mg BRF protein.


Lysis/Binding buffer, pH 8.0 (150 ml)

30mM Tris 8.00.54 g Tris
300mM NaCl2.63 g NaCl
6.0M Gu-HCl86 g Guanidine-HCl
10mM Imidazole0.1 g Imidazole

 

Wash Buffer, pH8.0 (200 ml)

30 mM Tris 8.00.73 g Tris
300mM NaCl3.5 g NaCl
8.0M Urea96.2 g Urea
10mM Imidazole0.136 g Imidazole

H2O to 200 ml final

Elution Buffer, pH 8.0 (50 ml)

20mM Tris 8.00.12 g Tris
300mM NaCl0.87 g NaCl
8.0M Urea24 g Urea
100mM Imidazole0.33 g Imidazole

H2O to 50 ml final

 


Renaturation of BRF protein

Thaw Ni-NTA purified samples. Dilute the sample to a concentration of 0.25 to 0.5mg/ml in the elution buffer. To the BRF sample, add 10% Brij58 detergent to a final concentration of 0.1% Brij, add DTT to 5 mM final concentration, add ZnS04 to a concentration of 20 micromolar, and add all protease inhibitors to 1X concentration. For each dialysis step, use a buffer to sample ratio of 40:1. Dialyze 4 times for four hours each time into decreasing amounts of Urea: 4M, then 2M, then 0.75M, and then 0M Urea. Spin renatured protein in the SS34 rotor for 10 min at 10K rpm. If a large pellet is detected, analyze the samples by SDS PAGE before proceeding with the purification to confirm that the renatured BRF is soluble.


BRF Renaturation Buffer (1.5 liters)

10% glycerol150 ml glycerol
20 mM HEPES 7.97.14 g HEPES
150 mM KCl16.8 g KCl
5 mM MgCl27.5 ml 1 M MgCl2
1 mM EDTA8 ml 0.25 M EDTA
20 micromolar ZnSO40.3 ml 0.1 M ZnSO4
0.1% Brij 581.5 g Brij 58

H2O to a final volume of 1.5 liters

Add protease inhibitors and DTT to 5 mM just prior to dialysis.

Protease inhibitors for BRF renaturation:

0.1 M PMSF (100x)

16 mg/ml Ethanol

Store at -20 degrees

Benzamidine (100X)

31 mg/ml H2O.

Store frozen at -20 degrees

Leupeptin (500X)

0.15 mg/ml Ethanol.

Store at -70 degrees for less than 6 months

Pepstatin (200X)

0.28 mg/ml methanol

Store at -20 degrees.

Chymostatin (2,500X)

5mg/ml DMSO

Store frozen at -20 degrees


Purification of BRF using SOURCE 15Q Ion Exchange Chromatography

Thaw the renatured BRF (in 150 mM KCl) and dilute with buffer B +0 KCl to a final KCl concentration of 50 mM. Filter the diluted sample through a 0.22 micron syringe filter before loading.

Load the filtered sample to a 0.5 ml SOURCE 15 Q column equilibrated in B + 50 mM KCl at a flow rate of 0.5 ml/min.

Wash the column with 6 column volumes of B + 50 mM KCl.

Elute with a 50 column volume gradient from 50 mM KCl to 550 mM KCl. Collect 0.5 ml fractions. BRF elutes in 2-3 fractions after about 1/3 of the gradient has completed at a conductivity of about 12 mS/cm-16mS/cm on the ATKA instrument. Expect 0.5- 1 mg of highly purified BRF protein from 10ml of renatured and diluted BRF.

Wash the column with 5 column volumes of B + 1.0 M KCl and 5 column volumes of 20% ETOH to clean. If the column pressure exceeds pressure limits and the ETOH cleaning does not cure the problem, follow the more extensive cleaning procedure recommended by Pharmacia.


Buffers for Ion Exchange Chromatography

B + 0 NaCl (500 ml)

30 mM Tris 8.01.82 g Tris
1 mM EDTA2 ml 0.25 M EDTA
10% glycerol50 ml glycerol

H2O to a final volume of 500 ml

B + 1 M NaCl (500 ml)

30 mM Tris 8.01.82 g Tris
1 mM EDTA2 ml 0.25 M EDTA
10% glycerol50 ml glycerol
1 M KCl37.3 g KCl

H2O to a final volume of 500 ml

Add DTT to 1 mM and protease inhibitors to 1x before use. Filter buffers through 0.22 micron filter before using on FPLC.

 

Pefablock (Boehringer) (1000x)

100 mg/ml H2O stock store at -20 deg.

Leupeptin (500X)

0.15 mg/ml Ethanol.

相关文章

科学家将人工智能技术成功用于蛋白质复合物结构预测

蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......

发力癌症分子病理诊断,无锡臻和全资收购TissueofOrigin®

2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......

这3个杂志撤回中国学者249篇文章,包含上交、中山等名校

2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......

肿瘤治疗的强心剂,中国学者开发肿瘤治疗新策略

磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......

岛津推出NexeraPrepPurificationLC可节省空间并多样品处理

分析测试百科网讯近日,岛津公司推出了NexeraPrep系列制备型纯化液相色谱仪(LC)。“制备工作”是从样品中分离和纯化特定物质的过程。该过程对于在制药工业中的药物发现期间提取目标化合物和杂质以及提......

llumina宣布推出新型基因分型芯片|支持AllofUs研究计划

2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......

SDSPAGE异常电泳现象及分析SDSPAGEHallofShame

SDS-PAGE异常电泳现象及分析SDS-PAGEHallofShame.pdf  很不错的东东~~推荐下~......

BovineGMCSF(YeastderivedRecombinantProtein)解决方案

活性氮(RNS)是巨噬细胞在称为氧化爆发的过程中响应病原体而产生的一组杀菌分子。一氧化氮(NO)是由精氨酸通过诱导的一氧化氮合酶(iNOS)产生的RNS的成员。刺激后巨噬细胞产生iNOS的活性和NO是......

牛GMCSF重组蛋白/BovineGMCSFRecombinantProtein

粒细胞-巨噬细胞集落刺激因子(granulocyte-macrophagecolony-stimulatingfactor,GM-CSF)主要由T细胞和巨噬细胞产生,能够诱导粒细胞前体和巨噬细胞前体细......

牛粒细胞巨噬细胞集落刺激因子/BovineGMCSF重组蛋白中英文说明书

艾美捷牛粒细胞-巨噬细胞集落刺激因子/BovineGM-CSF重组蛋白中文说明书:目录编号(规格):RP0871B-005(5µg)RP0871B-025(25µg)RP0871B-100(100µg......